Wheldon Christopher W, Sutton Steven K, Fontenot Holly B, Quinn Gwendolyn P, Giuliano Anna R, Vadaparampil Susan T
Department of Community and Family Health, University of South Florida, 13210 Bruce B. Downs Blvd., MDC56, Tampa, FL, 33612-3805, USA.
Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, FL, USA.
J Cancer Educ. 2018 Oct;33(5):1126-1131. doi: 10.1007/s13187-017-1223-6.
The Advisory Committee on Immunization Practices recommends that men who have sex with men (MSM) 26 years of age or younger be routinely vaccinated against HPV. For men outside of this risk-based population, the recommendation is routine vaccination until age 21. Thus, in order for this risk-based recommendation for MSM to be implemented, two distinct actions need to be completed during the clinical visit: (1) discuss recommendations for HPV vaccination with men and (2) assess sexual orientation to determine if a risk-based recommendation should be made. We assessed the degree to which physicians routinely discussed issues of sexual orientation and HPV vaccination with male patients 22-26 years old. We used data from a statewide representative sample of 770 primary care physicians practicing in Florida who were randomly selected from the American Medical Association Physician Masterfile. The analytic sample consisted of physicians who provided care to men 22-26 years old (N = 220). Response rate was 51%. Data collection took place in 2014 and analyses in 2016. Only 13.6% of physicians were routinely discussing both sexual orientation and HPV vaccination with male patients 22-26 years old, and approximately a quarter (24.5%) were not discussing either. Differences in these behaviors were found based on gender, Hispanic ethnicity, availability of HPV vaccine in clinic, HPV-related knowledge, and specialty. A minority of physicians in this sample reported engaging with these patients in ways that are mostly likely to result in recommendations consistent with current Advisory Committee on Immunization Practices guidelines.
免疫实践咨询委员会建议,26岁及以下与男性发生性行为的男性(MSM)应常规接种人乳头瘤病毒(HPV)疫苗。对于该基于风险的人群之外的男性,建议常规接种至21岁。因此,为了实施针对MSM的这一基于风险的建议,在临床就诊期间需要完成两项不同的行动:(1)与男性讨论HPV疫苗接种建议;(2)评估性取向以确定是否应给出基于风险的建议。我们评估了医生与22至26岁男性患者常规讨论性取向问题和HPV疫苗接种的程度。我们使用了来自佛罗里达州770名初级保健医生的全州代表性样本的数据,这些医生是从美国医学协会医生主文件中随机选取的。分析样本包括为22至26岁男性提供护理的医生(N = 220)。回复率为51%。数据收集于2014年进行,分析于2016年进行。只有13.6%的医生常规与22至26岁男性患者讨论性取向和HPV疫苗接种,约四分之一(24.5%)的医生两者都不讨论。基于性别、西班牙裔种族、诊所HPV疫苗的可获得性、HPV相关知识和专业领域,发现了这些行为上的差异。该样本中的少数医生报告称,他们与这些患者的沟通方式很可能会给出符合免疫实践咨询委员会当前指南的建议。